Absci Corporation logo ABSI - Absci Corporation

NEXT EARNINGS: Mar 17, 2026 (in 20 days) EPS Est: $-0.16 | Rev Est: $1.4M
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 1
SELL 2
STRONG
SELL
0
| PRICE TARGET: $6.16 DETAILS
HIGH: $8.00
LOW: $4.32
MEDIAN: $6.16
CONSENSUS: $6.16
UPSIDE: 127.31%
Market Cap: 407.51M
Volume: 2,072,786
Avg Volume: 3,652,578
52 Week Range: 2.01-5.228
Sector: Healthcare
Industry: Biotechnology
Beta: 2.12
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 156
IPO Date: 2021-07-22
EPS (TTM): -0.94
P/E Ratio: -2.80
Revenue (TTM): 4.53M
Total Assets: 213.61M
Total Debt: 10.11M
Cash & Equiv: 41.21M
Rev Growth (5Y): 17.1%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -58.1%
Debt/Equity: 0.06

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-12 $-0.20 $-0.19 -5.3% $378000 $1.4M -72.6%
2025-08-12 $-0.24 $-0.19 -26.3% $593000 $5.2M -88.5%
2025-05-13 $-0.21 $-0.23 +8.7% $1.2M $1.3M -9.3%
2025-03-18 $-0.25 $-0.22 -13.6% $665000 $4.9M -86.3%
2024-11-12 $-0.24 $-0.19 -26.3% $1.7M $1.8M -5.8%
2024-08-14 $-0.22 $-0.19 -15.8% $1.3M $1.9M -33.5%
2024-05-14 $-0.22 $-0.19 -15.8% $898000 $2.4M -62.9%
2024-03-21 $-0.25 $-0.23 -8.7% $338000 $1.0M -67.2%

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019
Revenue 4.53M 5.72M 5.75M 4.78M 4.78M 2.06M
Net Income (103.11M) (110.57M) (104.90M) (100.96M) (14.35M) (6.58M)
EPS -0.94 -1.20 -1.15 -1.11 -0.54 -0.07
Total Assets 213.61M 217.30M 321.01M 426.19M 88.57M 19.47M
Total Debt 10.11M 15.88M 22.98M 20.01M 14.50M 6.02M
Cash & Equivalents 41.21M 72.36M 59.95M 252.57M 69.87M 13.09M
Operating Cash Flow (72.40M) (64.64M) (81.34M) (60.60M) (10.97M) (6.03M)
Free Cash Flow (72.81M) (65.50M) (97.51M) (98.64M) (13.15M) (7.13M)
FCF per Share -0.66 -0.71 -1.07 -1.06 -0.14 -0.08
Book Value 179.13M 176.18M 274.41M 366.11M 67.00M (41.16M)
Cash & ST Investments 112.42M 97.66M 164.43M 252.57M 69.87M 13.09M
ROC Equity -0.58 -0.63 -0.38 -0.28 -0.21 N/A